What do you think of new BioPharm company Sirtris?

Question

Their discoveries and research look promising for Type 2 diabeties. But what do they have that the big boys don't?

Thank You

Answer 1

Fortune magazine likes them....
"Want to Live Forever?" pp. 68-80: Many of us have heard the stories that drinking one glass of red wine a day may prevent heart disease as well as other problems associated with the aging process. One biotech company, Sirtris Pharmaceuticals, based in Cambridge, Mass., has taken that idea to the next level by concentrating its research efforts on the benefits of resveratrol, a chemical found in trace amounts in the skin of red grapes. Former venture capitalist Christoph Westphal and Harvard medical school researcher David Sinclair have joined forces to examine the far-reaching effects resveratrol, which could potentially target diseases that accompany the aging process, such as weight gain, heart disease, diabetes, and Alzheimer's. Tests show that resveratrol activates a chain reaction at the cellular level, eventually generating new mitochondria, essentially replacing old ones that burned out while producing energy for an aging body. Ingesting highly concentrated does of resveratrol is not unlike replacing your home's older furnace with a new one offering improved efficiency and longer life. While adamant that it's not an anti-aging pill and many more trials are to come, Westphal and Sinclair remain cautiously optimistic about the amazing potential of a little pill.
SIRTRIS PHARMA INC. (NasdaqGM:SIRT)

After Hours: 14.93 0.23 (1.56%) as of 4:08PM ET on 07/12/07
52wk Range: 9.81 - 15.00
Market Cap: 408.50M
P/E (ttm): N/A
EPS (ttm): -0.89
Div & Yield: N/A (N/A)